HIT
Health In Tech·NASDAQ
--
--(--)
--
--(--)
HIT fundamentals
During Q3 2025, Health In Tech (HIT) reported revenue of 8.49M, a YoY change of 90.41%. Net income was 452.18K, a YoY change of 20.23%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 4.54M -- | 5.24M -- | 5.22M -- | 5.12M -- | 5.00M +10.22% | 4.46M -14.89% | 4.90M -5.98% | 8.01M +56.39% | 9.31M +86.18% | 8.49M +90.41% | 30.72M -- |
Sales and Services Revenue | 4.54M -- | 5.24M -- | 5.22M -- | 5.12M -- | 5.00M +10.22% | 4.46M -14.89% | 4.90M -5.98% | 8.01M +56.39% | 9.31M +86.18% | 8.49M +90.41% | 30.72M -- |
Cost of Revenue | 404.37K -- | 855.23K -- | 951.97K -- | 989.91K -- | 974.73K +141.05% | 979.63K +14.55% | 1.11M +16.30% | 2.66M +168.67% | 3.00M +208.19% | 3.35M +241.59% | 10.12M -- |
Cost of Goods and Services | -- -- | 855.23K -- | 951.97K -- | 989.91K -- | 974.73K -- | 979.63K +14.55% | 1.11M +16.30% | 2.66M +168.67% | 3.00M +208.19% | 3.35M +241.59% | 10.12M -- |
Gross Profit | 4.13M -- | 4.38M -- | 4.26M -- | 4.14M -- | 4.03M -2.58% | 3.48M -20.63% | 3.80M -10.95% | 5.36M +29.51% | 6.31M +56.66% | 5.14M +47.84% | 20.61M -- |
Operating Expenses | 3.80M -- | 3.87M -- | 2.81M -- | 3.80M -- | 3.49M -8.07% | 3.04M -21.34% | 4.11M +46.45% | 4.87M +28.20% | 5.58M +59.89% | 4.65M +52.95% | 19.22M -- |
Selling, General and Administrative Expenses | 3.35M -- | 3.36M -- | 2.14M -- | 3.04M -- | 2.79M -16.65% | 2.32M -30.98% | 3.48M +62.96% | 4.34M +42.55% | 5.00M +79.21% | 4.41M +90.12% | 17.23M -- |
Selling and Marketing Expenses | -- -- | 968.04K -- | 873.89K -- | 1.04M -- | 974.52K -- | 508.47K -47.47% | 632.06K -27.67% | 1.09M +4.51% | 1.23M +25.88% | 962.57K +89.31% | 3.91M -- |
General and Administrative Expenses | -- -- | 2.40M -- | 1.26M -- | 2.00M -- | 1.82M -- | 1.81M -24.32% | 2.85M +125.75% | 3.25M +62.40% | 3.78M +107.82% | 3.45M +90.34% | 13.32M -- |
Research and Development Expenses | 450.68K -- | 501.12K -- | 673.44K -- | 760.20K -- | 701.63K +55.68% | 718.42K +43.36% | 633.65K -5.91% | 537.72K -29.27% | 582.61K -16.96% | 235.82K -67.18% | 1.99M -- |
Operating Income | 334.93K -- | 518.14K -- | 1.46M -- | 332.42K -- | 534.94K +59.71% | 438.88K -15.30% | -316.34K -121.74% | 480.66K +44.59% | 725.07K +35.54% | 493.52K +12.45% | 1.38M -- |
Non-Operating Income (Loss) | 246 -- | 14.48K -- | 25.03K -- | -140.69K -- | -133.66K -54433.74% | -32.14K -322.00% | 205.59K +721.43% | 203.76K +244.83% | 108.20K +180.95% | 106.70K +431.95% | 624.25K -- |
Other Non-Operating Income (Loss) | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 94.40K -- | 176.81K -- | 118.40K -- | 0 -- | -5.00K -105.30% | 290.21K -- |
Net Interest Expense | -246 -- | -14.48K -- | -25.03K -- | 140.69K -- | 133.66K +54433.74% | 126.54K +973.96% | -28.77K -14.97% | -85.37K -160.68% | -108.20K -180.95% | -111.70K -188.27% | -334.04K -- |
Interest Expense | -- -- | 0 -- | 1.10K -- | 165.00K -- | 165.00K -- | 165.00K -- | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -100.00% | -- -- |
Interest Income | 246 -- | 14.48K -- | 26.13K -- | 24.31K -- | 31.34K +12639.43% | 38.46K +165.63% | 28.77K +10.11% | 85.37K +251.13% | 108.20K +245.25% | 111.70K +190.43% | 334.04K -- |
Pretax Income From Continuing Operations | 335.18K -- | 532.62K -- | 1.48M -- | 191.73K -- | 401.27K +19.72% | 406.74K -23.63% | -110.75K -107.48% | 684.42K +256.96% | 833.27K +107.66% | 600.22K +47.57% | 2.01M -- |
Income Tax Expense | 43.84K -- | 130.22K -- | 478.11K -- | 91.20K -- | 63.27K +44.30% | 30.65K -76.46% | 33.40K -93.01% | 185.83K +103.77% | 202.64K +220.28% | 148.05K +382.97% | 569.92K -- |
Current Income Tax | -- -- | -- -- | 811.75K -- | 151.27K -- | -- -- | -- -- | 311.83K -61.59% | 220.30K +45.64% | -- -- | -- -- | -- -- |
Deferred Income Tax | -- -- | -- -- | 133.49K -- | -60.07K -- | -- -- | -- -- | -93.30K -169.90% | -34.47K +42.61% | -- -- | -- -- | -- -- |
Income from Discontinued Operations | 542.31K -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- |
Net Income | 833.65K -- | 402.39K -- | 1.00M -- | 100.54K -- | 338.01K -59.45% | 376.09K -6.54% | -144.15K -114.38% | 498.59K +395.93% | 630.63K +86.57% | 452.18K +20.23% | 1.44M -- |
Net Income Attributable to Minority Interests | 542.31K -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Owners of the Company | 291.33K -- | 402.39K -- | 1.00M -- | 100.54K -- | 338.01K +16.02% | 376.09K -6.54% | -144.15K -114.38% | 498.59K +395.93% | 630.63K +86.57% | 452.18K +20.23% | 1.44M -- |
Net Income Attributable to Common Stockholders | 291.33K -- | 402.39K -- | 1.00M -- | 100.54K -- | 338.01K +16.02% | 376.09K -6.54% | -144.15K -114.38% | 498.59K +395.93% | 630.63K +86.57% | 452.18K +20.23% | 1.44M -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | 402.39K -- | 1.00M -- | 100.54K -- | 338.01K -- | -- -- | 670.48K -33.11% | 498.59K +395.93% | 630.63K +86.57% | -- -- | -- -- |
Basic EPS | 0.02 -- | 0.01 -- | -- -- | -- -- | 0.01 -50.00% | 0.01 -- | 0 -- | 0.01 -- | 0.01 -- | 0.01 -- | 0.03 -- |
Basic EPS from Continuing Operations | 0.01 -- | 0.01 -- | -- -- | 0 -- | 0.01 -- | 0.01 -- | -- -- | 0.01 -- | 0.01 -- | 0.01 -- | -- -- |
Basic EPS from Discontinued Operations | 0.01 -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Diluted EPS | 0.02 -- | 0.01 -- | -- -- | -- -- | 0.01 -50.00% | 0.01 -- | -- -- | 0.01 -- | 0.01 -- | 0.01 -- | -- -- |
Diluted EPS from Continuing Operations | 0.01 -- | 0.01 -- | -- -- | 0 -- | 0.01 -- | 0.01 -- | -- -- | 0.01 -- | 0.01 -- | 0.01 -- | -- -- |
Diluted EPS from Discontinued Operations | 0.01 -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
You can ask Aime
What is the market's earnings forecast for Health In Tech next quarter?What were the key takeaways from Health In Tech's earnings call?What factors drove the changes in Health In Tech's revenue and profit?What does Health In Tech do and what are its main business segments?Did Health In Tech beat or miss consensus estimates last quarter?What were the key takeaways from Health In Tech’s earnings call?What is the revenue and EPS growth rate for Health In Tech year over year?What is Health In Tech's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
